Discover how CC-292 and carfilzomib combination therapy targets both myeloma cells and bone destruction in multiple myeloma treatment.
Exploring the groundbreaking Phase I clinical trial of bortezomib in pediatric leukemia patients and its impact on cancer treatment.
Exploring the cellular mechanisms behind proteasome inhibitor resistance in multiple myeloma and emerging strategies to overcome this challenge in cancer treatment.